Additional file 2: of The BRCA1ness signature is associated significantly with response to PARP inhibitor treatment versus control in the I-SPY 2 randomized neoadjuvant setting

I-SPY 2 Trial participating sites and institutional review boards (IRB). (XLSX 48 kb)